| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |